NO980906D0 - New, anticonvulsant-acting 1-ar (alk) yl-imidazolin-2-ones, which at the 4-position contain a disubstituted amine residue and a process for their preparation - Google Patents

New, anticonvulsant-acting 1-ar (alk) yl-imidazolin-2-ones, which at the 4-position contain a disubstituted amine residue and a process for their preparation

Info

Publication number
NO980906D0
NO980906D0 NO980906A NO980906A NO980906D0 NO 980906 D0 NO980906 D0 NO 980906D0 NO 980906 A NO980906 A NO 980906A NO 980906 A NO980906 A NO 980906A NO 980906 D0 NO980906 D0 NO 980906D0
Authority
NO
Norway
Prior art keywords
imidazolin
anticonvulsant
alk
ones
acting
Prior art date
Application number
NO980906A
Other languages
Norwegian (no)
Other versions
NO313829B1 (en
NO980906L (en
Inventor
Hans-Joachim Lankau
Manfred Menzer
Klaus Unverferth
Karl Gewald
Harry Schaefer
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO980906(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of NO980906L publication Critical patent/NO980906L/en
Publication of NO980906D0 publication Critical patent/NO980906D0/en
Publication of NO313829B1 publication Critical patent/NO313829B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19980906A 1995-09-05 1998-03-02 Anticonvulsant-acting 1-ar (alk) yl-imidazolin-2-ones and their use in the preparation of compounds for the treatment of central nervous system diseases NO313829B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (en) 1995-09-05 1995-09-05 Novel, anticonvulsant 1-ar (alk) yl-imidazolin-2-ones which contain a disubstituted amine radical in the 4-position, and process for their preparation
PCT/EP1996/003295 WO1997009314A1 (en) 1995-09-05 1996-07-26 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production

Publications (3)

Publication Number Publication Date
NO980906L NO980906L (en) 1998-03-02
NO980906D0 true NO980906D0 (en) 1998-03-02
NO313829B1 NO313829B1 (en) 2002-12-09

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980906A NO313829B1 (en) 1995-09-05 1998-03-02 Anticonvulsant-acting 1-ar (alk) yl-imidazolin-2-ones and their use in the preparation of compounds for the treatment of central nervous system diseases

Country Status (32)

Country Link
EP (1) EP0863880B1 (en)
JP (1) JP4030578B2 (en)
CN (1) CN1103762C (en)
AR (1) AR003502A1 (en)
AT (1) ATE254606T1 (en)
AU (1) AU700602B2 (en)
BG (1) BG63917B1 (en)
BR (1) BR9610359A (en)
CA (1) CA2184871C (en)
CZ (1) CZ291839B6 (en)
DE (2) DE19532668A1 (en)
DK (1) DK0863880T3 (en)
EA (1) EA000535B1 (en)
EE (1) EE03562B1 (en)
ES (1) ES2208758T3 (en)
FR (1) FR13C0049I2 (en)
GE (1) GEP20022652B (en)
HK (1) HK1015776A1 (en)
HU (1) HU225956B1 (en)
IL (1) IL123333A (en)
LT (1) LT4482B (en)
LU (1) LU92263I2 (en)
NO (1) NO313829B1 (en)
NZ (1) NZ315624A (en)
PL (1) PL188287B1 (en)
PT (1) PT863880E (en)
SK (1) SK284868B6 (en)
TR (1) TR199800476T1 (en)
TW (1) TW422838B (en)
UA (1) UA46790C2 (en)
WO (1) WO1997009314A1 (en)
ZA (1) ZA967014B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (en) * 1997-05-23 1998-11-26 Dresden Arzneimittel Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
JP2009513539A (en) * 2003-07-11 2009-04-02 ベーリンガー・インゲルハイム・フエトメデイカ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Methods for treating or preventing central nervous system disorders using compounds having selectivity for the alpha 3 subunit of a benzodiazepine receptor
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
MX2014001556A (en) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Taste masked pharmaceutical composition.
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (en) 2021-01-18 2022-07-18 Procos Spa PROCESS FOR THE SYNTHESIS OF IMEPITOIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (en) 1971-10-21 1973-04-20 American Cyanamid Co NEW (P-CHLORO) PHENYL-1 METHYL-3 IMIDAZOLIDINES, 2,4-DISUBSTITUTIONS USEFUL IN PARTICULAR AS ANTIALDOSTERONE DIURETIC AGENTS AND THEIR PREPARATION PROCESS
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
WO1997009314A1 (en) 1997-03-13
IL123333A (en) 2001-10-31
SK284868B6 (en) 2006-01-05
PT863880E (en) 2004-04-30
LT4482B (en) 1999-03-25
DE19532668A1 (en) 1997-03-06
JP4030578B2 (en) 2008-01-09
AU6737596A (en) 1997-03-27
HU225956B1 (en) 2008-01-28
EP0863880A1 (en) 1998-09-16
EE03562B1 (en) 2001-12-17
NO313829B1 (en) 2002-12-09
CA2184871A1 (en) 1997-03-06
EA000535B1 (en) 1999-10-28
PL188287B1 (en) 2005-01-31
BG63917B1 (en) 2003-06-30
CN1103762C (en) 2003-03-26
CZ66198A3 (en) 1998-07-15
TW422838B (en) 2001-02-21
JPH11512101A (en) 1999-10-19
CZ291839B6 (en) 2003-06-18
EE9800063A (en) 1998-08-17
DE59610827D1 (en) 2003-12-24
CN1200728A (en) 1998-12-02
ES2208758T3 (en) 2004-06-16
TR199800476T1 (en) 1998-06-22
UA46790C2 (en) 2002-06-17
EA199800271A1 (en) 1998-10-29
AU700602B2 (en) 1999-01-07
AR003502A1 (en) 1998-08-05
HUP9802941A3 (en) 1999-10-28
IL123333A0 (en) 1998-09-24
DK0863880T3 (en) 2004-03-22
HK1015776A1 (en) 1999-10-22
ATE254606T1 (en) 2003-12-15
LT98047A (en) 1998-10-26
BR9610359A (en) 1999-07-06
GEP20022652B (en) 2002-03-25
NO980906L (en) 1998-03-02
MX9801742A (en) 1998-08-30
HUP9802941A2 (en) 1999-09-28
CA2184871C (en) 2001-08-21
EP0863880B1 (en) 2003-11-19
LU92263I2 (en) 2013-10-07
SK21698A3 (en) 1998-10-07
FR13C0049I1 (en) 2013-09-27
PL325413A1 (en) 1998-07-20
BG102287A (en) 1998-09-30
ZA967014B (en) 1997-08-18
FR13C0049I2 (en) 2014-03-28
NZ315624A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
DK0855999T3 (en) 1- (1,2-Disubstituted piperidinyl) -4-substituted piperidine derivatives as tachykinin receptor antagonists
NO981534D0 (en) 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives
NO20005454D0 (en) Novel hydroxy indoles, their use as phosphodiesterase 4 inhibitors and process for their preparation
NO20005224L (en) BTK inhibitors and methods for their identification and use
TR199600930A2 (en) Crystalline structure (R) - (-) - 2- {N- £ 4- (1,1-dioxido-3-oxo-2, 3-dihydrobenzisothiazol-2-yl) -butyl | - aminomethyl} -chromane hydrochloride.
DE69827557D1 (en) Device for aligning parts.
NO964654D0 (en) New erythromycin derivatives, processes for their preparation and their use as pharmaceuticals
DE69919632D1 (en) Fault tolerance through N-modular software redundancy using indirect instrumentation
DK0858440T3 (en) Process for preparing 1,1,1,3,3-pentafluoropropane
DK0885234T3 (en) New erythromycin derivatives, methods for their preparation and their use as pharmaceuticals
NO985671L (en) New Thiazolidinedione-2 derivatives which are 4-diketone substituted process
DK0843679T3 (en) 1- (1,2-Disubstituted Piperidinyl) -4- (Condensed Midazole) Piperidine Derivatives
DK1045856T3 (en) Novel aromatic amides, processes for their preparation and their use as pharmaceuticals
AR004368A1 (en) SUBSTITUTED PIPERIDINE -1, -4 COMPOUNDS, PROCEDURES FOR PREPARING THEM AND A PROCEDURE FOR PREPARING 1-BENCIL-4 - ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE THROUGH THESE COMPOUNDS.
NO980906D0 (en) New, anticonvulsant-acting 1-ar (alk) yl-imidazolin-2-ones, which at the 4-position contain a disubstituted amine residue and a process for their preparation
NO951928D0 (en) Cementing system for extension tubes, as well as method
NO982708D0 (en) Novel phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals
NO953321D0 (en) 2.3 cyclic condensed 1,4-dihydropyridines, process for their preparation and their use as drugs
NO20002588L (en) Bifenylamidinderivater
DK199901582A (en) Plate bending machine, tool holder part and bending tool respectively
DK0906326T3 (en) New aromatic derivatives substituted by a ribose, process for their preparation and their use as drugs
DK0946579T3 (en) New compounds derived from erythromycin, methods for their preparation and their use as drugs
EP1620857A4 (en) Enabling memory redundancy during testing
ITVI910109A1 (en) PRESSURE REGULATOR FOR GAS.
DK1157020T3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-ols, processes for their preparation and their use as a drug

Legal Events

Date Code Title Description
MK1K Patent expired